Clinical Trial Update: Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating A140 plus Erbitux with the mFOLFOX6 regimen as first-line treatment for Ras wild-type metastatic colorectal cancer has completed enro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• A140
• ERBITUX (cetuximab)
• MFOLFOX6

Snippet

Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: COMPLETED